The amniotic membrane market is expected to reach US$ 2,808.39 million by 2028; registering at a CAGR of 7.4% from 2022 to 2028, according to a new research study conducted by The Insight Partners
Cryopreserved Amniotic Membrane Segment to Lead Market During 2020–2028
The report highlights trends prevailing in the market and factors driving its growth. The market's growth is attributed to the rising usage of amniotic membranes in eye surgery. However, the breakdown of membranes is hindering the growth of the global amniotic membrane market.
Based on enzyme, the global amniotic membrane market is divided into cryopreserved amniotic membrane and dehydrated amniotic membrane. The cryopreserved amniotic membrane segment captured a larger share in 2019 and is expected to continue a similar trend during the forecast period. Cryopreservation was first introduced by Lee and Tseng and has been proven to achieve a high success rate in amniotic membrane transplantation. It has been distinguished from many other types of methods due to its advantages such as prolonging use span, optimally retaining tissue structure, and minimizing infection risk. On the other hand, the dehydrated amniotic membrane segment is expected to witness higher growth during the forecast period owing to its longer shelf life.
Lucrative Regions for Amniotic Membrane Market
Amniotic Membrane Market Developments by 2031
Download Free Sample
Amniotic Membrane Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: by Enzyme (Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane), Application (Surgical Wounds, Ophthalmology, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research Institute & Academic Institutes), and Geography (North America, Europe, Asia Pacific, and South and Central America)
Amniotic Membrane Market Developments by 2031
Download Free SampleAmniotic Membrane Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: by Enzyme (Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane), Application (Surgical Wounds, Ophthalmology, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research Institute & Academic Institutes), and Geography (North America, Europe, Asia Pacific, and South and Central America)
Based on application, the amniotic membrane market has been segmented into surgical wounds, ophthalmology, and others. The surgical wounds segment captured the largest share in 2019 and is expected to continue a similar trend during the forecast period. Owing to the presence of a large number of cytokines and essential growth factors, the amniotic membrane is an ideal option for treating surgical wounds. This also enhances the wound-healing process.
Based on end user, the amniotic membrane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and academic & research institutes. In 2019, the hospitals segment held the largest share of the amniotic membrane market and is expected to continue a similar trend during the forecast period. The adoption of new technology methods by hospitals across the globe has resulted in the growth of the overall industry. Amniotic membrane therapy is an option for those at risk of limb amputation. The amniotic membrane is a sustainable and powerful option, especially with new preservation techniques that allow amniotic membranes to be available across various clinical settings such as hospitals, clinics, specialty clinics, and ambulatory surgical centers.
In June 2022, according to the Scientific Journal of the Royal College of Ophthalmologists, the amniotic membrane proved to having great potential for healing ophthalmologic wounds. This was shown to be RT-PCR positive for viral RNA in two critically ill pregnant females with COVID-19. Amniotic fluid specimen too, tested RT-PCR positive in an earlier case report of possible maternal-foetal transmission. While there is no confirmed data on the survival of SARS CoV-2 in cryopreserved amniotic membranes, it is clear that temperature strongly influences viral persistence (>2 weeks survival at 4 °C vs only 2 days at 20 °C).
Applied Biologics LLC; Integra Life Sciences Corporation; Skye Biologics Inc.; MiMedx; Organogenesis Inc.; Smith & Nephew; Amniox Medical, Inc.; Katena Products, Inc.; Amnio technology, LLC.; and Surgenex, LLC are among the leading companies in the global amniotic membrane market. The market is anticipated to flourish with the development of new innovative products by market players.
The report segments the amniotic membrane market as follows:
The amniotic membrane market is segmented into enzyme, application, end user, and geography. Based on enzyme, the global amniotic membrane market is divided into cryopreserved amniotic membrane and dehydrated amniotic membrane. Based on application, the amniotic membrane market has been segmented into surgical wounds, ophthalmology, and others. Based on end user, the amniotic membrane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and academic & research institutes. Based on geography, the amniotic membrane market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com